Search

everythinglearnresearchcommunity

for

Search:↓

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

The new method found new shared genetic areas linked to both Type 2 Diabetes and Prostate Cancer.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.